Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing a pan-NOS inhibitor through clinical development for patients with the hardest-to-treat forms of advanced breast cancer.
Back to dashboard
Company Information
About this company
Key people
Dana Alexander
Executive Officer
Julie Feder
Executive Officer
Parameswaran Hari
Executive Officer
Madan Jagasia
Executive Officer
Click to see more
Key facts
- Shares in issue1.04m
- EPICOBX
- ISINUS67448A1060
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capGBX 0.00
- Employees3
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.